Deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds
US10626105B2 · kind B2 · utility
5Cited by
2References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 20, 2017 |
| Grant date | Apr 21, 2020 |
| Priority date | — |
| Expiry date | Sep 20, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described are deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds of structural Formula (I), which are agonists of 5-hydroxytryptamine receptors. Also described are pharmaceutical compositions comprising the deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds, and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.